by myhealthteam | Oct 21, 2024 | Uncategorized
By Eric Peacock, Co-founder and CEO, MyHealthTeam R&D in rare diseases has skyrocketed. Thirty percent of today’s R&D pipeline is in rare diseases, and 40 percent of overall pipeline growth since 2013 is due to rare diseases. As the leading creator of patient...
by myhealthteam | May 29, 2024 | Uncategorized
This year’s PHM HealthFront highlighted themes which pharma, agencies, and marketers should make central to all we do. Below are 10 quotes from the stage that really resonated with all of us at MyHealthTeam. 1. “Community is the cornerstone of health advocacy. … If...
by myhealthteam | Dec 7, 2023 | Uncategorized
As the industry faces the depreciation of third-party cookies, pharma marketers and ad agencies are looking for new ways to effectively target diagnosed patients. Here are four tactics that can be launched in-market within a matter of weeks that allow brands to engage...
by myhealthteam | Oct 12, 2023 | Uncategorized
Written by Mary Ray, Co-founder and COO, MyHealthTeam It was three and a half years ago when I felt swept up by a wave of biopsies, surgeries, and a myriad of medical appointments after being diagnosed with breast cancer. Juxtaposed against the daunting backdrop of a...
by myhealthteam | Jul 12, 2023 | Uncategorized
By Eric Peacock, CEO and Co-founder, MyHealthTeam What Is Zero Party Data? You may have heard the phrase “zero party data,” but you’re still wondering what it means. Zero party data is information a customer intentionally and proactively shares with a company,...
